- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Sofinnova Venture Partners X, L.P.
- Signature - Title
- /s/ Nathalie Auber - Nathalie Auber / Attorney-in-Fact
- Location
- Menlo Park, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Sofinnova Venture Partners X, L.P..
Follow Filing Activity
Follow Sofinnova Venture Partners X, L.P. and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Sofinnova Venture Partners X, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | Class A Common Stock, $0.001 par value | 4% | $128,465,927 | 2,847,837 | Dr. Maha Katabi ("Katabi") | 10 Dec 2025 | ||
| JBIO | Jade Biosciences, Inc. | Common Stock, par value $0.0001 per share | 0.3% | $1,617,308 | 107,391 | Sofinnova Venture Partners X, L.P. ("SVP X") | 28 Apr 2025 |
Schedules 13D/G Reported by Sofinnova Venture Partners X, L.P.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.